TrialDrug design, development and therapy2026

Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III Study.

Jong-Chan Youn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.